Evidence map›Paper›PMID 38782781›Full record

ArticleAnalytical and bioanalytical chemistry2024

Development of a nine-variant reference material panel to standardize cell-free DNA detection.

Chunyan Niu, Jiejie Zhang, Yan Fang, Xia Wang, Yanru Tang, Lianhua Dong

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chunyan NiuCenter for Advanced Measurement Science, National Institute of Metrology, Beijing, 100013, China.
Jiejie ZhangCenter for Advanced Measurement Science, National Institute of Metrology, Beijing, 100013, China.
Yan FangCenter for Advanced Measurement Science, National Institute of Metrology, Beijing, 100013, China.
Xia WangCenter for Advanced Measurement Science, National Institute of Metrology, Beijing, 100013, China.
Yanru TangCenter for Advanced Measurement Science, National Institute of Metrology, Beijing, 100013, China.
Lianhua DongCenter for Advanced Measurement Science, National Institute of Metrology, Beijing, 100013, China. donglh@nim.ac.cn.

Funding

National Institute of Metroloty, China AKYZD2202
6 · The paper itself

Abstract

Detection of specific gene mutations in cell-free DNA (cfDNA) serves as a valuable cancer biomarker and is increasingly being explored as an appealing alternative to tissue-based methods. However, the lack of available reference materials poses challenges in accurately evaluating the performance of different assays. In this study, we present the development of a comprehensive reference material panel for cfDNA detection, encompassing nine hotspot mutations in KRAS/BRAF/EGFR/PIK3CA at three variant allele frequencies (VAFs), ranging from 0.33 to 23.9%. To mimic cfDNA, these reference materials were generated by enzymatically digesting cell-line DNA into approximately 154-bp to 173-bp fragments using a laboratory-developed reaction system. The VAFs for each variation were precisely determined through validated digital PCR assays with high accuracy. Furthermore, the reliability and applicability of this panel were confirmed through two independent NGS assays, yielding concordant results. Collectively, our findings suggest that this novel reference material panel holds great potential for validation, evaluation, and quality control processes associated with liquid biopsy assays.

Indexed as

Cell-Free Nucleic AcidsProto-Oncogene Proteins B-rafReference StandardsBiomarkers, TumorCell Line, TumorClass I Phosphatidylinositol 3-KinasesErbB ReceptorsGene FrequencyHumansLiquid BiopsyMutationPolymerase Chain ReactionProto-Oncogene Proteins p21(ras)Reproducibility of ResultsBiomarkers, TumorBRAF protein, humanCell-Free Nucleic AcidsClass I Phosphatidylinositol 3-KinasesEGFR protein, humanErbB ReceptorsKRAS protein, humanPIK3CA protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)cfDNAdPCRGene mutationNGSSomatic cell

Identifiers

PMID38782781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.